Navigation Links
Phalanx Biotech Group Launches microRNA Microarray - miRBase v17

BELMONT, Calif., Aug. 24, 2011 /PRNewswire/ -- Phalanx Biotech Group, a global provider of genomic products and services, launches a major update to its OneArray® microRNA expression profiling microarrays based on the latest miRBase release – Version 17.  This miRBase release represents a significant increase over Version 16 in the number of microRNA sequences with 2,406 additional mature microRNA - of which 563 represent newly verified sequences in human, mouse and rats.  Researchers using OneArray® microRNA products will benefit from more comprehensive interrogation power of validated microRNA transcripts as opposed to those using Affymetrix, Agilent or Exiqon microarrays based on older miRBase versions. The OneArray® microRNA line includes human, mouse, rat and seven major plant species - rice, corn, soybean, grapevine, Sorghum, Arabidopsis, and Brachypodium.  

"At Phalanx Biotech, we continuously strive to make improvements in probe coverage, performance, and usability for all of our OneArray microarray products. This latest microRNA product release marks the third update to our microRNA product line, and features not only the most current annotation, but also a new hybridization chemistry enabling greater microarray signal intensities at reduced sample input," said Richard Su, Head of Product Development. "Furthermore, as our whole genome gene expression microarray product line expands, we anticipate a set of complementary microRNA microarrays to offer researchers the capability to conduct gene and microRNA expression profiling studies in parallel."

About microRNA

MicroRNA or miRNA are short ribonucleic acid molecules (approximately 22 nucleotides long) that often play roles in regulating the expression of genes, usually by binding to target messenger RNA (mRNA) sequences and impeding their function through mRNA degradation or blocking the translation of mRNA.  Researchers are focusing their efforts in uncovering the regulatory circuitry afforded by microRNA – investigating the role of microRNA in processes as diverse as embryonic development, cell proliferation, differentiation, and apoptosis.  Comparative microRNA expression profiling studies among different cell populations and tissue types demonstrate increasing correlations between microRNA and disease.  The combination of gene expression and microRNA profiles will enhance our understanding of biological mechanisms and the genes associated in these processes.  

About Phalanx Biotech Group

Phalanx Biotech Group, with operations in California and Taiwan, provides genomics research products and services worldwide to academic, pharmaceutical and biotech communities. Built on world-class, integrated-chip foundry technology, Phalanx Biotech has developed the OneArray® line of high-quality and affordable microarrays for expression profiling of whole genomes, microRNA, and custom targets.  Our highly-trained service specialists provide a comprehensive offering of gene expression and microRNA profiling services for biomarker discovery including sample preparation, expression analysis, and qPCR validation. For more information about our products and services, please visit our website at

Kevin Poon, 1-650-320-8669 ext 111

SOURCE Phalanx Biotech Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Spaulding Clinical Announces Strategic Partnership with Clinigene International, India for Providing Comprehensive Early Clinical Solutions to Pharmaceutical and Biotech Clients
2. VacChina 2011 - Bridging the China Vaccine Industry with the World Class Biotechnologies
3. IU Confidential Publishes Biotech Investment Report
4. Australian Biotech Ceridia Pty Ltd Completes Successful Human Clinical Trial
5. Top 5 Ways to Get Insider Track on Healthcare, Pharma & Biotech Discoveries & Latest News
6. Aeras and China National Biotech Group Sign Memorandum of Understanding for TB Vaccine R&D Collaboration
7. 2011 Prix Galien USA Final Candidates Announced: Competing for Best Biotechnology Product and Best Pharmaceutical Agent
8. Lilly Announces New Investment to Further Boost Its Biotechnology Capabilities
9. Goodwin Biotechnology Announces a Collaboration With Alethia Biotherapeutics
10. TriLink BioTechnologies, Inc. Awarded European Patent for CleanAmp™ Primers
11. Olympus Biotech Names Oliver Burckhardt to President North America
Post Your Comments:
(Date:6/24/2016)... Mass. and SAN CLEMENTE, Calif. , ... California -based mobile pulmonary function testing company, is now able ... PFT devices developed by ndd Medical Technologies , Inc. ... testing done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® ... , can get any needed testing done in the comfort ...
(Date:6/24/2016)... , June 24, 2016 VolitionRx ... of Dr. Edward Futcher to the ... effective June 23, 2016.Dr. Futcher was also appointed ... Governance Committees.  As a non-executive member of the ... and strategic counsel to VolitionRx in connection with ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice ... X users can now reveal the media of their split screens with growing ...
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
Breaking Medicine News(10 mins):